External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

WCLC 2026

We will be contributing to topics related to
-
12:30 AM
Duration 24hrs Seoul, Republic of Korea
Challenges in interpretation of pathologic response in patients with ALK-rearranged NSCLC receiving alectinib in NAUTIKA1
Anjali Saqi, Jamie Chaft, Edward Kadel, Akila Gopalakrishnan, Beiying Ding, Evelise Brandao, Celina Ngiam, Ilze Bara, Jay M. Lee, Lynette Sholl
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
01:30 AM
Duration 90mins Seoul, Republic of Korea
NAUTIKA1: pathological response and safety of neoadjuvant entrectinib▼ or atezolizumab + radiation in biomarker-selected NSCLC
Elaine Shum, Amy Cummings, Andreas Saltos, Nisha Mohindra, Eric M. Toloza, Sibo Tian, David Kozono, Nitin Ohri, Katja Schulze, Qian Zhu, Evelise Brandao, Celina Ngiam, Ilze Bara, Jay M. Lee, Jamie Chaft
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:37 AM
Duration 10mins Seoul, Republic of Korea
Final Analysis of the Phase 3 IMpower030 Study: Perioperative Atezolizumab + Chemotherapy in Resectable Stage IIB–IIIB NSCLC
Benjamin Solomon, Catherine A. Shu, Solange Peters, David Gandara, David P. Carbone, Makoto Nishio, Alessandro Brunelli, Harvey Pass, Anjali Saqi, Maximilian Hochmair, Igor Bondarenko, Rafal Dziadziuszko, Antonio Chella, Christian Schulz, Bertrand Mennecier, Martin Reck, Masashi Kobayashi, Shaun Mohan, Saket Jain, Chenqi Fu, Pao-Chen Li, ​Marcus Ballinger, Barbara J. Gitlitz, Anthony W. Kim​
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:47 AM
Duration 10mins Seoul, Republic of Korea
Neoadjuvant Divarasib Shows Manageable Safety and Promising Activity in Resectable KRAS G12C+ NSCLC: Updated NAUTIKA1 Data
Jamie Chaft, Amy Cummings, Nisha Mohindra, Marcelo V. Negrao, Kai He, So Yeon Kim, Andreas Saltos, ​Tejas Patil, Elaine Shum, Philip Lammers, Katja Schulze, Qian Zhu, Mark Lin, Evelise Brandao, Celina Ngiam, Ilze Bara, Jay M. Lee​
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:12 AM
Duration 10mins Seoul, Republic of Korea
ASTRES: A Phase 2, Single-Arm Study of Atezolizumab in Locally Advanced, Unresectable, Stage III, Non-Small Cell Lung Cancer
Enriqueta Felip, Luis Corrales, Yun Fan, Emilio Esteban Gonzalez, Le Thi Le Quyen, Patricia Iranzo, Danielli Matias, Mehmet Ali Nahit Sendur, Anh Pham, Ahmet Sümbül, Martina Vrankar, Gustavo Zerwes, Min Zhou, Shwetha Chiluveru, Anna Greco, Jessie J. Hsu, Polina Zhornikova, Francisco Orlandi
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:32 AM
Duration 5mins Seoul, Republic of Korea
NAUTIKA1: Primary analysis of neoadjuvant alectinib in resectable stage IB−IIIB ALK+ NSCLC
Jay M. Lee, Amy Cummings, Najust Florez, Nisha Mohindra, Dennis Wigle, Jules Lin, Catherine A. Shu, Andreas Saltos, Elaine Shum, Marcelo V. Negrao, Tejas Patil, Lynette Sholl, Anjali Saqi, Edward Kadel, Beiying Ding, Celina Ngiam, Ilze Bara, Jamie Chaft​
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:05 AM
Duration 5mins Seoul, Republic of Korea
Expression and Prognostic Impact of B7-H3 in Patients with Extensive-Stage Small-Cell Lung Cancer
Stephen V. Liu, Charles M. Rudin, Solange Peters, Martin Reck, Shun Lu, Ross A. Soo, Hossein Borgahei, Roy Herbst, Pao-Chen Li, Virginia McNally, Stefanie Morris, Hartmut Koeppen, Barzin Nabet, Minu K. Srivastava, Luis Paz-Ares
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon